<DOC>
	<DOC>NCT00171106</DOC>
	<brief_summary>This study will test the effects of valsartan versus placebo on exercise tolerance in patients with symptoms of heart failure</brief_summary>
	<brief_title>Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Symptomatic diastolic heart failure Breathlessness with physical exertion Uncontrolled hypertension Asthma, COPD, or abnormal lung function History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm Liver, kidney, or pancreas disease Allergy to valsartan Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>diastolic dysfunction</keyword>
	<keyword>heart failure</keyword>
	<keyword>exercise tolerance</keyword>
	<keyword>valsartan</keyword>
</DOC>